Clinical Trials Directory

Trials / Unknown

UnknownNCT01776814

Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Gachon University Gil Medical Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Chronic hepatitis B virus infection is an important cause of morbidity and mortality. Tenofovir disoproxil fumarate and entecavir were licensed for the treatment of hepatitis B virus infection. In this study, the investigators will try to make comparison between Entecavir and Tenofovir and investigate the efficacy.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2013-02-01
First posted
2013-01-28
Last updated
2013-01-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01776814. Inclusion in this directory is not an endorsement.

Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With (NCT01776814) · Clinical Trials Directory